Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity
Open Access
Abstract
Infant acute myeloid leukemia (AML) is a rare subgroup of AML of children <2 years of age. It is as frequent as infant acute lymphoblastic leukemia (ALL) but not clearly distinguished by study groups. However, infant AML demonstrates peculiar clinical and biological characteristics, and its prognosis differs from AML in older children. Acute megakaryoblastic leukemia (AMKL) is very frequent in this age group and has raised growing interest. Thus, AMKL is a dominant topic in this review. Recent genomic sequencing has contributed to our understanding of infant AML. These data demonstrated striking features of infant AML: fusion genes are able to induce AML transformation without additional cooperation, and unlike AML in older age groups there is a paucity of associated mutations. Mice modeling of these fusions showed the essential role of ontogeny in the infant leukemia phenotype compared to older children and adults. Understanding leukemogenesis may help in developing new targeted treatments to improve outcomes that are often very poor in this age group. A specific diagnostic and therapeutic approach for this age group should be investigated.Keywords
This publication has 58 references indexed in Scilit:
- Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene–Driven Myeloid LeukemiaCancer Discovery, 2019
- Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study GroupHemaSphere, 2019
- Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilitiesBlood Advances, 2019
- Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroupBritish Journal of Haematology, 2019
- The efficiency of murine MLL-ENL–driven leukemia initiation changes with age and peaks during neonatal developmentBlood Advances, 2019
- The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactionsNature Medicine, 2017
- Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomesNature Genetics, 2017
- Acute Myeloid Leukemia in Infants: Biology and TreatmentFrontiers in Pediatrics, 2015
- Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002/01 protocol have an outcome comparable to that of older childrenHaematologica, 2014
- Acute Myeloid LeukemiaHematology/Oncology Clinics of North America, 2010